News in the Life Sciences Industry

UPPSALA, Sweden, April 11, 2019 /PRNewswire/ --

STOCKHOLM, April 11, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) today announced that it has updated its financial calendar, the interim report for Q2 2019 have been moved to 28 August.

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.

GETINGE, Sweden, April 10, 2019 /PRNewswire/ -- Getinge is today announcing clearance from the US Food & Drug Administration (FDA) for a new software version for the Servo-u® and Servo-n® mechanical ventilator platform. This software release includes the addition of Servo Compass®... Read more ››

UPPSALA, Sweden, April 10, 2019 /PRNewswire/ -- Biovica has agreed on a collaboration with IBL-America for sales of DiviTum® for the research market in the US. The partnership will further increase the commercial activities for this customer segment on the single largest market... Read more ››

OSLO, Norway, April 10, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that the Safety Review Committee (SRC) for the ongoing LYMRIT 37-05 clinical trial of single-administration Betalutin® (177Lu-satetraxetan-lilotomab) in patients with relapsed/refractory diffuse large B-cell... Read more ››

LUND, Sweden, April 10, 2019 /PRNewswire/ -- Immunovia today announced that Prof. Stephen Pereira and his team at the institute for Liver and Digestive Health, University College London (UCL) will expand the prospective collection of blood samples funded by Immunovia and that started with the... Read more ››

STOCKHOLM, April 10, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) today announced that the US patent and trademark office has issued a notice that they intend to grant additional patents to Oncopeptides AB in the US. Oncopeptides has previously received the corresponding... Read more ››

HUDDINGE, Sweden, April 10, 2019 /PRNewswire/ -- The shareholders of Medivir AB (publ) are hereby summoned to the annual general meeting on Thursday 9 May 2019 at 2 p.m. at the IVA's conference center, Grev Turegatan 16, Stockholm.

LUND, Sweden, April 10, 2019 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that Chief Medical Officer Charlotte Russell, MD, PhD, will give an oral presentation on its bispecific CTLA-4 x OX40 antibody ATOR-1015 at PEGS, the Essential Protein Engineering... Read more ››

LINKÖPING, Sweden and TORONTO, April 10, 2019 /PRNewswire/ --International medical imaging IT and cybersecurity company Sectra... Read more ››

WASHINGTON, April 9, 2019 /PRNewswire/ -- Johnson & Johnson Innovation LLC and Read more ››

LUND, Sweden, April 9, 2019 /PRNewswire/ -- Camurus' (NASDAQ STO: CAMX) US partner, Braeburn Inc., today announced that the company today will file an action in federal district court for the District of Columbia, seeking to overturn the 3-year market exclusivity granted by the US Food and Drug... Read more ››

BERGEN, Norway, April 9, 2019 /PRNewswire/ -- BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company focused on developing a pipeline of first-in-class drug candidates targeting AXL kinase to treat aggressive diseases including immune-evasive and therapy resistant cancers, announces... Read more ››